Arkolith/Insider Trading/INO/Form 4

Sumner Michael John

Chief Medical OfficerINOVIO PHARMACEUTICALS, INC. (INO) · full profile →Form 4 · filed May 21, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)9K——45K
May 20, 2026Tax withholding(F)3K$1.23$3K42K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)9K—$019K
May 20, 2026Grant(A)47K—$047K
May 20, 2026Grant(A)38K—$038K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001936799-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML